HKBU presents the Third Cheung On Tak International Award for Outstanding Contribution to Chinese Medicine to Academician Lee Kuo-hsiung and Professor Guo Dean
08 Apr 2016
The School of Chinese Medicine (SCM) presented today (8 April) the “Third Cheung On Tak International Award for Outstanding Contribution to Chinese Medicine” to Academician Lee Kuo-hsiung and Professor Guo Dean, renowned experts in research on Chinese medicine in recognition of their tremendous contribution to new drug discovery based on Chinese herbal medicines and research on quality standards of Chinese medicines respectively.
The ceremony was officiated by Mr Gavin Cheung, Director, Cheung On Tak Charity Foundation; Mr Cheng Yan-kee, Chairman of HKBU Council and Court; Professor Roland Chin, President and Vice-Chancellor of HKBU; and Professor Lu Aiping, Dean of Chinese Medicine of HKBU.
Academician Lee Kuo-hsiung is Academician of Academia Sinica in Taiwan, and Kenan Distinguished Professor of Medicinal Chemistry and Director of Natural Products Research Laboratories, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill in US. A scholar of international renown, Academician Lee has been using approaches based on medicinal chemistry to investigate Chinese herbal medicines for the purpose of discovering and developing new drug candidates and new drugs. With continuing funding support from National Institutes of Health, US and other sources over the past four decades, his research team has studied nearly 200 Chinese herbal medicines and discovered several thousand novel bioactive natural products and their synthetic analogs, providing leads for a new generation of drugs against AIDS, cancer and other diseases.
Professor Guo Dean is Chair Professor of Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Director of National Engineering Laboratory for TCM Standardisation Technology, and Director of Shanghai Research Center for Modernisation of Traditional Chinese Medicine. Professor Guo is the first Chinese scientist to introduce traditional Chinese medicine (TCM) standards into the United States Pharmacopoeia and European Pharmacopoeia. With more than 30 years’ experience in conducting research on modernisation of TCM, he has established a method to analyse the active ingredients of TCM and developed a standard system for holistic quality control of TCM, which have been adopted as standards of the Chinese Pharmacopoeia, United States Pharmacopoeia and Europe Pharmacopoeia.
At the Award Winners’ Lectures following the ceremony, Academician Lee Kuo-hsiung gave a talk entitled “Chinese Herbal Medicine (CHM) and New Drug Discovery and Development”. He is of the view that quality control is the first prerequisite for internationalisation of CHM. Academician Lee explained to the participants the methods for discovering world-class standardised new CHM drugs by making reference to several examples that are in clinical use, clinical trials and preclinical development.
In a talk entitled “Elaboration of Holistic TCM Quality Standards and Its Applications”, Professor Guo Dean said that as a complex system involving multiple components, the conventional quality control model based on one single marker fails to completely control the quality of TCM, and has become a bottleneck hindering the healthy development of TCM industry and TCM globalisation. He further elaborated on the formulation and application of the model for TCM quality standard.
The biennial Cheung On Tak International Award for Outstanding Contribution to Chinese Medicine was launched by HKBU in 2011 to recognise scientists and scholars who have made outstanding contributions to the internationalisation of Chinese medicine or breakthroughs in Chinese medicine research for the purpose of fostering the development of Chinese medicine and promoting its modernisation and internationalisation.